Clasado Biosciences, a prominent developer of prebiotic ingredients, has expanded into the pet nutrition space in response to the growing demand for animal gut health solutions.
The company, headquartered in Reading, UK, said the global pet food market is expected to reach US$161.6 billion by 2028, at a compound annual growth rate (CAGR) of 5.2%. With growing interest in prebiotics for animal health, the company is introducing the Bimuno Pet brand to support pet nutrition formulators.
“For 20 years, Classad has been at the forefront of prebiotic research and development, primarily focused on human health applications,” said CEO Per Reine. “As we celebrate our 20th anniversary, we are leveraging our expertise in the gut microbiome to support the rapidly growing field of pet nutrition. represents an opportunity to contribute to the health and well-being of people.
The company’s prebiotic ingredient, Bimuno GOS, has been widely studied in the GOS (galactooligosaccharides) category with support from over 120 scientific publications, including over 20 clinical trials.
The effectiveness of Bimuno GOS has been demonstrated in the areas of gastrointestinal health, intestinal health, immune health and immune defense. Bimuno GOS is associated with health claims specific to pet nutrition in certain markets such as China and Taiwan, and can be used on packaging and marketing materials.
Stephen Reilly, Head of B2B and Corporate Marketing, said: “Due to increased microbiome awareness across the market, the pet nutrition market is seeing a surge in demand for products that support gut health.” “We can meet this demand head-on by applying our extensive knowledge of prebiotic galactooligosaccharides to support animal health.
“The pet nutrition market is rapidly growing as owners seek to continually improve the quality of their pets’ lives,” Riley continued. “Gut health is a natural focus in this regard, and of course prebiotics as well.”
Created based on press release.
